You are here
Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID --study
Primary tabs
Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID --study
Wed, 2024-10-30 09:51 — mike kraft Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID Paxlovid was associated with a 61% lower risk of hospitalization. CIDRAP
A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.
The study was published today in Scientific Reports and adds to the understand of the usefulness of Paxlovid in the Omicron-variant period.
..
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
Recent Comments